Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY20 results · Jul–Sep 2019
Sanofi India reported revenue from operations of ₹779.10 crore (up 4.7% from Q2 FY19) and net profit of ₹126.60 crore (up 6.2% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a standalone basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 779.10 | 743.80 | +4.7% | 747.90 | +4.2% |
| Other income | 22.90 | 26.20 | −12.6% | 23.40 | −2.1% |
| Total income | 802.00 | 770.00 | +4.2% | 771.30 | +4.0% |
| Profit before tax | 132.70 | 187.50 | −29.2% | 155.20 | −14.5% |
| Net profit for the period | 126.60 | 119.20 | +6.2% | 97.40 | +30.0% |
| EPS, basic (₹) | 54.96 | 51.83 | +6.0% | 42.29 | +30.0% |
| Net margin (%) | 16.2 | 16.0 | 13.0 |
Standalone
- Filed with BSE
- 13 Nov 2019, 12:21 IST
- Board meeting
- 12 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE